A number of firms have modified their ratings and price targets on shares of SomaLogic (NASDAQ: SLGC) recently: 5/13/2022 – SomaLogic was upgraded by analysts at Zacks Investment Research from a “sell” rating to a “hold” rating. According to Zacks, “SomaLogic Inc. provides AI-data driven proteomics technology. SomaLogic Inc., formerly known as CM Life Sciences […]